The Tata Memorial Centre, Mumbai, the premier tertiary cancer treatment and research centre in South Asia and one of the largest globally, is on the cusp of a momentous year, namely, the 75th year of its existence.
It gives us great pleasure to invite you to “A Conference of New Ideas in Cancer – Challenging Dogmas” to commemorate TMC’s platinum jubilee celebrations. The idea for the conference came from surveying the current landscape of cancer research and treatment and the disappointments that it has brought us. The last decade has been particularly frustrating as we have realized that the hype generated from molecular and genetic ‘breakthroughs’ are translating neither into a meaningful understanding of the malignant process nor to a clinically relevant relief to our patients. In our desperate quest to prove our scientific approach to be right, we are even modifying our time-tested methodologies of clinical research, and getting increasingly excited by meaningless gains of “progression free survival” by a few months. A 2%-3% improvement in overall survival has become the outer limit of our intellectual expectation.
This platinum jubilee conference will be devoted to challenging the current dogmas and to debate the ‘currently entrenched versus contrarian viewpoints’ in cancer research and treatment. Key international speakers and participants will deliberate on these issues critically over 3 days of the conference on carefully chosen themes in the form of symposia, debates and special lectures. Some of the emerging messages may lead to potentially paradigm shifting approaches to how we perceive and treat cancer. We are sure that the conference will be an academic feast and would appeal to all scientists, clinicians and health care professional involved in researching and treating cancer. It is likely to be a landmark conference – the first of its kind!
The conference will be held at the National Centre for Performing Arts in Mumbai and the iconic Taj Mahal Palace Hotel has agreed to be our official hospitality partners. We have managed to get very attractive registration packages for the participants with special concessional rates for students and delegates from the SAARC countries.
The Lancet Oncology, the US NCI and AACR have agreed to be our partners.
We look forward to seeing you in large numbers